Sirolimus Quantitative Testing Drug - Vietnam Registration 2402896ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Sirolimus Quantitative Testing Drug in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402896ĐKLH/BYT-HTTB and manufactured by Fujirebio Diagnostics, Inc.. The authorized representative in Vietnam is VĂN PHÒNG ĐẠI DIỆN ABBOTT LABORATORIES GMBH TẠI THÀNH PHỐ HÀ NỘI.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2402896ĐKLH/BYT-HTTB
000.00.04.G18-230615-0005
Alinity i Sirolimus Reagent Kit
09P4120
Technical Details
Alinity i Sirolimus Testing is a chemiluminescent microparticle immunoassay (CMIA) used to quantitate sirolimus in the total blood of humans on the Alinity i system. Alinity i Sirolimus Testing is used to support the management of patients undergoing sirolimus therapy for kidney transplantation.
Dates and Status
Oct 22, 2024